Molecular Therapy
Volume 30, Issue 9, 7 September 2022, Pages 2984-2997
Original ArticleAn intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa
Under a Creative Commons license
open archive
Graphical abstract
Keywords
intranasal vaccination
lentiviral vaccine
SARS-CoV-2 emerging variants of concern
mucosal immunity
mucosal booster vaccine
waning anti-COVID-19 immunity
Cited by (0)
© 2022 The American Society of Gene and Cell Therapy.